Anhar Hassan1, Shivam Om Mittal2, William T Hu2, Keith A Josephs2, Eric J Sorenson2, J Eric Ahlskog2. 1. From the Department of Neurology (A.H., K.A.J., E.J.S., J.E.A.), Mayo Clinic, Rochester, MN; Department of Neurology (S.O.M.), Cleveland Clinic Abu Dhabi, United Arab Emirates; and Department of Neurology (W.T.H.), Emory University, Atlanta, GA. hassan.anhar@mayo.edu. 2. From the Department of Neurology (A.H., K.A.J., E.J.S., J.E.A.), Mayo Clinic, Rochester, MN; Department of Neurology (S.O.M.), Cleveland Clinic Abu Dhabi, United Arab Emirates; and Department of Neurology (W.T.H.), Emory University, Atlanta, GA.
Abstract
OBJECTIVE: To assess whether primary lateral sclerosis (PLS), classified as pure when the EMG is normal, converts to amyotrophic lateral sclerosis (ALS) after longitudinal follow-up. METHODS: Retrospective chart review was performed of patients with pure PLS at Mayo Clinic in Rochester, MN (1990-2016). Inclusion criteria required a normal EMG during the first 4 years of symptoms. RESULTS: Forty-three patients had pure PLS (25 female, 58%) with a median onset age of 50 years (range 38-78 years) and median follow-up at 9 years' disease duration (range 4-36 years). The ascending paraparesis phenotype (n = 30, 70%) was most common, followed by hemiparetic onset (n = 9, 21%) and bulbar onset (n = 4, 9%). Among the 30 paraparetic-onset cases, bladder symptoms (n = 18, 60%) and dysarthria (n = 15, 50%) were more common than pseudobulbar affect (n = 9, 30%) and dysphagia (n = 8, 27%). By the last follow-up, 17 of 30 (56%) used a cane and 6 (20%) required a wheelchair. The paraparetic variant, compared with hemiparetic and bulbar onset, had the youngest onset (48 vs 56 vs 60 years, respectively; p = 0.02). Five patients died; 1 patient required a feeding tube; and none required permanent noninvasive ventilation. Two patients developed an idiopathic multisystem neurodegenerative disorder, which surfaced after 19 and 20 years. Two patients developed minor EMG abnormalities. The remainder 39 had persistently normal EMGs. CONCLUSIONS: Pure PLS did not convert to ALS after a median of 9 years' disease duration follow-up in our study population. The ascending paraparetic phenotype was most common, with earlier onset and frequent bladder involvement. After years of pure PLS, <5% develop a more pervasive neurodegenerative disorder.
OBJECTIVE: To assess whether primary lateral sclerosis (PLS), classified as pure when the EMG is normal, converts to amyotrophic lateral sclerosis (ALS) after longitudinal follow-up. METHODS: Retrospective chart review was performed of patients with pure PLS at Mayo Clinic in Rochester, MN (1990-2016). Inclusion criteria required a normal EMG during the first 4 years of symptoms. RESULTS: Forty-three patients had pure PLS (25 female, 58%) with a median onset age of 50 years (range 38-78 years) and median follow-up at 9 years' disease duration (range 4-36 years). The ascending paraparesis phenotype (n = 30, 70%) was most common, followed by hemiparetic onset (n = 9, 21%) and bulbar onset (n = 4, 9%). Among the 30 paraparetic-onset cases, bladder symptoms (n = 18, 60%) and dysarthria (n = 15, 50%) were more common than pseudobulbar affect (n = 9, 30%) and dysphagia (n = 8, 27%). By the last follow-up, 17 of 30 (56%) used a cane and 6 (20%) required a wheelchair. The paraparetic variant, compared with hemiparetic and bulbar onset, had the youngest onset (48 vs 56 vs 60 years, respectively; p = 0.02). Five patients died; 1 patient required a feeding tube; and none required permanent noninvasive ventilation. Two patients developed an idiopathic multisystem neurodegenerative disorder, which surfaced after 19 and 20 years. Two patients developed minor EMG abnormalities. The remainder 39 had persistently normal EMGs. CONCLUSIONS: Pure PLS did not convert to ALS after a median of 9 years' disease duration follow-up in our study population. The ascending paraparetic phenotype was most common, with earlier onset and frequent bladder involvement. After years of pure PLS, <5% develop a more pervasive neurodegenerative disorder.
Authors: N Le Forestier; T Maisonobe; A Piquard; S Rivaud; L Crevier-Buchman; F Salachas; P F Pradat; L Lacomblez; V Meininger Journal: Brain Date: 2001-10 Impact factor: 13.501
Authors: Mike A Singer; Suleiman Kojan; Richard J Barohn; Laura Herbelin; Sharon P Nations; Jaya R Trivedi; Carlayne E Jackson; Dennis K Burns; Philip J Boyer; Gil I Wolfe Journal: J Clin Neuromuscul Dis Date: 2005-09
Authors: Sabrina Paganoni; Fabiola De Marchi; James Chan; Sara K Thrower; Nathan P Staff; Neil Datta; Yaz Y Kisanuki; Vivian Drory; Christina Fournier; Erik P Pioro; Stephen A Goutman; Nazem Atassi; Maryangel Jeon; Sarah Caldwell; Timothy Mcdonough; Caroline Gentile; Jianing Liu; Michelle Turner; Carol Denny; Kevin Felice; Misty Green; Stephanie Scarberry; Saad Abu-Saleh; Beatrice Nefussy; Debbie Hastings; Sangri Kim; Blake Swihart; Ximena Arcila-Londono; Daniel S Newman; Michael Silverman; Angela Genge; Kristiana Salmon; Lauren Elman; Leo Mccluskey; Kelly Almasy; Marc Gotkine; Kimberly Goslin; Arlena Cummings; Eli K Edwards; Michael Rivner; Kristy Bouchard; Brandy Quarles; Justin Kwan; Matthew Jaffa; Robert Baloh; Peggy Allred; David Walk; Samuel Maiser; Georgios Manousakis; Valerie Ferment; J Americo M Fernandes; Pariwat Thaisetthawatkul; Deborah Heimes; Melissa Phillips; Laura Sams; Melissa Kahler; Alecia Corcoran; Daniel G Larriviere; Sadie Chotto; Gracy Juba Journal: Amyotroph Lateral Scler Frontotemporal Degener Date: 2020-09-11 Impact factor: 4.092
Authors: Jennifer L Whitwell; Nirubol Tosakulwong; Hugo Botha; Farwa Ali; Heather M Clark; Joseph R Duffy; Rene L Utianski; Chase A Stevens; Stephen D Weigand; Christopher G Schwarz; Matthew L Senjem; Clifford R Jack; Val J Lowe; J Eric Ahlskog; Dennis W Dickson; Keith A Josephs Journal: Neuroimage Clin Date: 2019-12-28 Impact factor: 4.881
Authors: Jonathan M Schott; Sebastian J Crutch; Minerva M Carrasquillo; James Uphill; Tim J Shakespeare; Natalie S Ryan; Keir X Yong; Manja Lehmann; Nilufer Ertekin-Taner; Neill R Graff-Radford; Bradley F Boeve; Melissa E Murray; Qurat Ul Ain Khan; Ronald C Petersen; Dennis W Dickson; David S Knopman; Gil D Rabinovici; Bruce L Miller; Aida Suárez González; Eulogio Gil-Néciga; Julie S Snowden; Jenny Harris; Stuart M Pickering-Brown; Eva Louwersheimer; Wiesje M van der Flier; Philip Scheltens; Yolande A Pijnenburg; Douglas Galasko; Marie Sarazin; Bruno Dubois; Eloi Magnin; Daniela Galimberti; Elio Scarpini; Stefano F Cappa; John R Hodges; Glenda M Halliday; Lauren Bartley; Maria C Carrillo; Jose T Bras; John Hardy; Martin N Rossor; John Collinge; Nick C Fox; Simon Mead Journal: Alzheimers Dement Date: 2016-03-15 Impact factor: 21.566